From GlobeNewswire:

Cytek Biosciences, Inc. will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on January 11 at 8:15 a.m. Pacific Time. Interested parties can access a live and archived webcast of the presentation on the company’s website. Cytek Biosciences is a leading cell analysis solutions company with headquarters in Fremont, California. The company’s CEO, Dr. Wenbin Jiang, will present and participate in a Q&A session at the conference. Cytek advances the next generation of cell analysis tools with its patented Full Spectrum Profiling technology, which includes instruments, cell sorting, flow cytometry and imaging products, as well as reagents, software and services. The company’s products are for research use only and not for diagnostic procedures, except in China and the European Union. Cytek Biosciences’ communication and products can be found through its website, LinkedIn page and X account. For clarification or inquiries, a media and investor contact is available.



Read more: Cytek Biosciences to present at the 42nd Annual J.P. Morgan